Recent clinical trials suggest that upadacitinib, originally an arthritis medication, may provide significant benefits for patients battling severe alopecia areata. Remarkably, nearly 50% of participants on a 15 mg dose reported considerable hair regrowth. Even more striking, those on higher doses enjoyed near-complete recovery of their scalp hair. This breakthrough offers renewed hope for individuals suffering from hair loss linked to autoimmune conditions.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.